Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Saturday, January 28, 2023.
Gain Therapeutics, Inc. (NASDAQ:GANX)
Long-Term Uptrend (+90) - GANX is in a strong uptrend that is likely to continue. While GANX is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid GANX?
MarketClub looks at technical strength and momentum to determine if the timing is right for GANX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for GANX
The long-term trend has been UP since Jan 10th, 2023 at 3.465
The intermediate-term trend has been UP since Jan 3rd, 2023 at 3.170
The short-term trend has been UP since Jan 20th, 2023 at 3.890
Smart Scan Analysis for GANX
Based on our trend formula, GANX is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 4.22 | 4.22 | 4.01 | 4.07 | -0.18 |
| Prev. Close | Volume | Bid | Ask | Time |
| 4.25 | 40519 | 2023-01-27 15:59:51 |
| 52wk High | 6.7 | 52wk High Date | 2022-04-12 |
| 52wk Low | 2.33 | 52wk Low Date | 2022-05-24 |
| Average Volume | 53,051 | Shares Outstanding | 11,883 |
| Assets | 28,325,619M | Liabilities | 5,662,858M |